MLPH | Melanophilin | Disease related genes Plasma proteins
| | | | | Tissue enhanced |
MME | Membrane metallo-endopeptidase | Cancer-related genes Candidate cardiovascular disease genes CD markers Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
MPO | Myeloperoxidase | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enriched |
MS4A1 | Membrane-spanning 4-domains, subfamily A, member 1 | CD markers Disease related genes FDA approved drug targets Predicted membrane proteins Transporters
| | | | | Group enriched |
MUC1 | Mucin 1, cell surface associated | Cancer-related genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
MUC5AC | Mucin 5AC, oligomeric mucus/gel-forming | Predicted secreted proteins
| | | | | Tissue enriched |
MYL4 | Myosin, light chain 4, alkali; atrial, embryonic | Plasma proteins
| | | | | Tissue enriched |
MYO1B | Myosin IB | | | | | | Tissue enhanced |
NCAM1 | Neural cell adhesion molecule 1 | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
NCF1 | Neutrophil cytosolic factor 1 | Disease related genes
| | | | | Tissue enhanced |
NCS1 | Neuronal calcium sensor 1 | | | | | | Tissue enhanced |
NES | Nestin | Plasma proteins
| | | | | Tissue enhanced |
NPY | Neuropeptide Y | Plasma proteins Predicted secreted proteins
| | | | | Group enriched |
NQO1 | NAD(P)H dehydrogenase, quinone 1 | Cancer-related genes Enzymes
| | | | | Tissue enhanced |
OXCT1 | 3-oxoacid CoA transferase 1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
PEG10 | Paternally expressed 10 | | | | | | Tissue enhanced |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes
| | | | | Tissue enhanced |
PKP3 | Plakophilin 3 | Plasma proteins
| | | | | Tissue enhanced |
PLCB3 | Phospholipase C, beta 3 (phosphatidylinositol-specific) | Enzymes
| | | | | Group enriched |
PLEK | Pleckstrin | Plasma proteins
| | | | | Tissue enhanced |
PNMA5 | Paraneoplastic Ma antigen family member 5 | | | | | | Group enriched |
PODXL | Podocalyxin-like | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
POF1B | Premature ovarian failure, 1B | Disease related genes
| | | | | Tissue enhanced |
POU2F2 | POU class 2 homeobox 2 | Cancer-related genes Transcription factors
| | | | | Tissue enhanced |
PPBP | Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7) | Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
PPL | Periplakin | Cytoskeleton related proteins Mitochondrial proteins Plasma proteins
| | | | | Tissue enhanced |
PTGES | Prostaglandin E synthase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
PVALB | Parvalbumin | | | | | | Group enriched |
RAB11FIP3 | RAB11 family interacting protein 3 (class II) | Cancer-related genes
| | | | | Tissue enriched |
RAB3B | RAB3B, member RAS oncogene family | | | | | | Tissue enhanced |
RAP1GAP | RAP1 GTPase activating protein | | | | | | Tissue enhanced |
RASAL3 | RAS protein activator like 3 | RAS pathway related proteins
| | | | | Tissue enhanced |
RBP1 | Retinol binding protein 1, cellular | | | | | | Tissue enhanced |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
RIPK2 | Receptor-interacting serine-threonine kinase 2 | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
S100A14 | S100 calcium binding protein A14 | Plasma proteins
| | | | | Tissue enhanced |
SAMSN1 | SAM domain, SH3 domain and nuclear localization signals 1 | | | | | | Tissue enhanced |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
SATB2 | SATB homeobox 2 | Disease related genes Transcription factors
| | | | | Group enriched |
SIX1 | SIX homeobox 1 | Disease related genes Transcription factors
| | | | | Group enriched |
SLC2A1 | Solute carrier family 2 (facilitated glucose transporter), member 1 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
SLC35F1 | Solute carrier family 35, member F1 | Predicted membrane proteins Transporters
| | | | | Tissue enriched |
SNCA | Synuclein, alpha (non A4 component of amyloid precursor) | Cytoskeleton related proteins Disease related genes Plasma proteins Potential drug targets Transporters
| | | | | Tissue enhanced |
SOAT1 | Sterol O-acyltransferase 1 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |
SPINK2 | Serine peptidase inhibitor, Kazal type 2 (acrosin-trypsin inhibitor) | Predicted secreted proteins
| | | | | Tissue enriched |
SPN | Sialophorin | CD markers Predicted membrane proteins
| | | | | Tissue enhanced |
SPTB | Spectrin, beta, erythrocytic | Disease related genes Plasma proteins
| | | | | Group enriched |
STXBP1 | Syntaxin binding protein 1 | Disease related genes Plasma proteins
| | | | | Tissue enriched |
SV2A | Synaptic vesicle glycoprotein 2A | FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enriched |